KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Long-Term Investments (2016 - 2025)

Biogen (BIIB) has 16 years of Long-Term Investments data on record, last reported at $431.9 million in Q4 2025.

  • For Q4 2025, Long-Term Investments changed N/A year-over-year to $431.9 million; the TTM value through Dec 2025 reached $431.9 million, changed N/A, while the annual FY2025 figure was $431.9 million, N/A changed from the prior year.
  • Long-Term Investments reached $431.9 million in Q4 2025 per BIIB's latest filing, up from $100000.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $1.2 billion in Q2 2023 and bottomed at $100000.0 in Q3 2023.
  • Average Long-Term Investments over 4 years is $823.8 million, with a median of $903.6 million recorded in 2021.
  • Peak YoY movement for Long-Term Investments: grew 21.86% in 2022, then tumbled 99.99% in 2023.
  • A 4-year view of Long-Term Investments shows it stood at $892.0 million in 2021, then decreased by 20.89% to $705.7 million in 2022, then tumbled by 99.99% to $100000.0 in 2023, then skyrocketed by 431800.0% to $431.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $431.9 million in Q4 2025, $100000.0 in Q3 2023, and $1.2 billion in Q2 2023.